Funding for this research was provided by:
Counsyl (Internal funding, Internal funding, Internal funding)
Received: 24 April 2018
Accepted: 15 November 2018
First Online: 11 January 2019
: LB is a board certified genetic counselor with clinical and laboratory experience solely in cancer genetics, focusing on delivering alternative service models for patient identification and genetic counseling. She is the Manager of Clinical Products at Counsyl. She serves as an appointed committee chair for both the National Society of Genetic Counselors (NSGC) and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA).KJT holds a PhD, in molecular, cell, and developmental biology, and has extensive experience in clinical genomics research and policy development. She is the Director of Clinical Development at Counsyl.KR is a board certified genetic counselor with clinical and laboratory experience in cancer genetics, serving as Director of Inherited Cancer at Counsyl. She is a past Board of Director member of the National Society of Genetic Counselors (NSGC).
: Ethical approval for this study was obtained through review by Western Institutional Review Board. The study was designated as exempt, and the need for consent was waived.
: Consent for publication is not applicable. No individual data or case reports are included.
: The authors of this study are employed by Counsyl, developer of the digital ID tool that is assessed by this research. The authors have made every effort to adhere to the Good Publication Practice guidelines (GPP3) to ensure that this publication is produced in a responsible and ethical manner.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.